ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effects of combination therapy with Shenfu Injection in critically ill patients with septic shock receiving mechanical ventilation: A multicentric, real-world study

Li, Xiaoqian; Huang, Fan; Zhu, Lixia; Luo, Tianyi; Zhang, Yuzhuo; Gu, Huiwen; Guo, Liheng*; Mao, Shuai*广东省人民医院; 广州中医药大学
Frontiers in Pharmacology2022-11-9DOI: 10.3389/fphar.2022.1041326
2被引22阅读
引用收藏
分享

摘要

Background: Septic shock has increasingly become a cause of death threatening human survival. Shenfu Injection (SFI), a patented Chinese medicine, has been widely used in the treatment of patients with sepsis and cardiovascular diseases domestically. We sought to examine whether combination therapy with SFI can improve clinical outcomes in critically ill patients undergoing mechanical ventilation (MV). Methods: This real-world, multicenter retrospective trial enrolled consecutive adult patients with sepsis requiring MV from four medical/surgical intensive care units (ICUs) in China between August 2016 and September 2021. Patients were identified from the medical information department database of each center and assigned to either of two groups (SFI or control) on the basis of the initial treatment received. The primary outcome was 28-day all-cause mortality, and the durations of vasopressor therapy and MV, the ICU length of stay, and costs were assessed as secondary outcomes. Subsequently, we performed a meta-analysis of randomized controlled trials (RCTs) on SFI published before July 2021 to verify our conclusions. Results: 2311 mechanically ventilated patients with septic shock (1128 patients in the SFI group and 1183 in the control group) were analyzed. The survival probability during the first 28 days after admission in the SFI group was greater than that in the control group [p < 0.01 by log-rank test; hazard ratio (HR), 0.56; 95% confidence interval (CI), 0.39-0.72]. Patients in the SFI group also experienced a significantly reduced duration of vasopressor therapy [7.28 (95% CI, 6.14-8.42) vs. 12.06 (95% CI, 10.71-13.41) days, p < 0.001], more ventilator-free days [6.49 (95% CI, 5.42-7.55) vs. 10.84 (95% CI, 9.59-12.09) days, p < 0.001], a shorter ICU length of stay [18.48 (95% CI, 17.59-19.38) vs. 23.77 (95% CI, 22.47-25.07) days, p < 0.001], and more time free from organ failure [14.23 (95% CI, 12.94-15.52) vs. 19.07 (95% CI, 16.09-22.05) days, p < 0.001]. No major adverse effects were reported in either group. Conclusion: Among critically ill patients requiring MV, combination therapy with SFI can improve the survival probability without any obvious adverse reactions.

学科与关键词

关键词
septic shockShenfu injectioncombination therapymechanical ventilationcritically ill patientsmeta-analysisretrospective study
相关
加载中…
  • Shenfu injection attenuates cardiac dysfunction and inhibits apoptosis in septic mice br
    Zhao, Liyun; Jin, Lili; Luo, Yuanyuan; Wang, Ling; Li, Yinghong; Xian, Shaoxiang*; Zhao, Fengli*Annals of Translational Medicine, 2022, 10(10).被引 6
  • Comparative efficacy of Chinese herbal injections for septic shock A protocol for systematic review and network meta-analysis
    Huang, Peiying; Chen, Yan; Liu, Qiang; Lei, Sisi; Feng, Yuchao; Wu, Qihua; Zhang, Haobo; Chen, Bojun; Zeng, Zhongyi*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2022, 101(5): e28183.
  • Efficacy and Safety of Shenfu Injection on Acute Heart Failure: A Systematic Review and Meta-Analysis
    Tao, Lanting; Mo, Zhaofan; Li, Zunjiang; Li, Shuang; Luo, Ziqing; Li, Dongli; Wang, Dawei; Zhu, Wei*; Ding, Banghan*PHYTOMEDICINE, 2023, 110: 154641.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2022-11-09
卷期
第 13 卷
页码
1041326
DOI
10.3389/fphar.2022.1041326
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Wu Jieping Medical FoundationRunze Fund for Critical Care Medicine; National Science Foundation [82074216]; Science and Technology Planning Project ofGuangzhou [202102010242]; SHI Zai-xiangAcademic Thought Inheritance Studio [2014-89]; TraditionalChinese Medicine Bureau of Guangdong Province [20201144, 20221190]; Guangdong Provincial Hospital of Chinese Medicine [YN2020QN04]

作者

  • L

    Li, Xiaoqian (第一作者)

    2 · guangzhou univ chinese med

  • H

    Huang, Fan

    guangdong prov hosp

查看全部 8 位作者收起作者
  • Z

    Zhu, Lixia

  • L

    Luo, Tianyi

  • Z

    Zhang, Yuzhuo

  • G

    Gu, Huiwen

  • G

    Guo, Liheng (通讯)

    2 · guangzhou univ chinese med · guangdong prov hosp

  • M

    Mao, Shuai (通讯)

    2 · guangzhou univ chinese med · guangdong prov hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417